|
Product complaint # (b)(4).Attempts are being made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: where was the foreign material found? (inside the sterile barrier or outside of the sterile barrier?) inside the sterile barrier.Is it possible that the foreign material fell into packaging upon opening of device? no.Was the product seal on the foil still intact when the package was opened? yes.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
It was reported that the patient underwent a thyroid and parathyroid resection procedure on an unknown date and absorbable hemostat was used.When the doctor was unpacking and preparing to use the product during the operation, doctor found black spots on the gauze and color difference, with the gauze turning yellow in color.Changed to another one to complete the surgery.No patient consequences were reported.Additional information was requested.
|
|
Product complaint # (b)(4).Corrected information: d 9.Device available for evaluation?, h 3.Device evaluated by manufacturer? additional information: d 9.Date device returned to manufacturer, d 9.Is device returned to manufacturer?, h6.Component code, h 6.Type of investigation, h 6.Investigation findings, h 6.Investigation conclusions.H6 component code: g07002 - no device problem found.H 6.Investigation findings: c22 ¿ photo evaluation.H3 investigation summary: the product was returned to ethicon for evaluation.One open sample was received for analysis.Product code 2082.Additionally, four photos were provided, and it showed the same condition of the samples received.The visual assessment of the sample revealed dirt or dark stain on the folder and on the surgicel product, which appears to be unrelated to the manufacturing process.Also, surgicel product was noted to be as expected and no defect color on the surgicel could be observed during the evaluation.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.No conclusion could be reached as to what caused the reported complaint.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of post-market surveillance.A manufacturing record evaluation was performed for the finished device batch and no non-conformances were identified.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|